Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines
- 1 October 1988
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 27 (3) , 233-240
- https://doi.org/10.1007/bf00205445
Abstract
To avoid non-specific binding of intact ricin-antibody conjugates, we prepared a new blocked thioether-linkedricin-antibody IT, in which the galactosebinding site of ricin had lost the ability to bind to galactosidic residues of Sepharose 6B gel. As carrier agent, the monoclonal antibody AR-3, which defines the CAR-3 tumour-associated antigenic determinant expressed selectively on different human carcinoma cell lines, was used. Purification of the new conjugate was performed in three sequential steps: (1) by HPLC gel filtration on TSK G3000SW to remove the unconjugated ricin: (2) by affinity chromatography on Affi-Gel Blue to separate the free antibody from the conjugate and (3) by affinity chromatography on Sepharose 6B to separate the galactose-binding IT from the non-binding moiety. The cytotoxicity of the blocked and non-blocked thioether-linked IT was compared with that of classical ricin-antibody IT conjugated via SPDP and that of ricin A chain IT. The comparison was made on two different target cell lines (KATO III human gastric carcinoma and HT-29 human colorectal carcinoma) versus two control cell lines (HL-60 promyelocytic pre-leukaemic and COLO38 melanoma). The results showed that the blocked thioether IT displayed a more selective toxicity to target cells than the non-blocked IT and was much more potent than the ricin A chain conjugate.Keywords
This publication has 38 references indexed in Scilit:
- Interaction of cibacron blue F3GA and polynucleotides with ricin A-chain, 60 S ribosomal subunit-inactivating proteinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxinJournal of Neurosurgery, 1987
- The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodiesInternational Journal of Immunopharmacology, 1987
- Prospects for Immunotoxin Therapy in CancerAnnual Review of Medicine, 1986
- ImmunotoxinsAnnual Review of Immunology, 1985
- MONOCLONAL ANTIBODY-TOXIN CONJUGATES REACTIVE AGAINST HUMAN T LYMPHOCYTESTransplantation, 1984
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983
- Neoplastic B Cells as Targets for Antibody‐Ricin A Chain ImmunotoxinsImmunological Reviews, 1982
- The interaction of Ricinus communis agglutinin with normal and tumor cell surfacesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970